Walleye Trading Advisors »

Crispr Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.4M 55k 62.60
2023-09-30 $1.9M 42k 45.39
2023-06-30 $2.5M 44k 56.14
2023-03-31 $1.7M 38k 45.23
2022-12-31 $3.0M 74k 40.65
2022-09-30 $2.0M 30k 65.32
2019-09-30 $817k 20k 41.16
2019-06-30 $410k 8.7k 47.12
2019-03-31 $329k 9.2k 35.77